BUPA departing with a healthy surplus

BUPA claims risk equalisation would cost it €161m over the next three years compared with projected profits of €64m under the current system.

That’s approximately €21m per annum profit generated through the surplus of premium income over costs — principally staff, marketing and medical claims.

This return reflects BUPA’s relatively young customer base whose age profile would automatically mean a lower incidence of claims.